Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

Completed

Conditions studied: Primary Open Angle Glaucoma

In brief

The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100R/L in subjects previously enrolled in Glaukos Study GC-003.

Key facts

Study ID

NCT01836042

Run by

Glaukos Corporation

People needed

108

Starts

2013-07-01

Expected to finish

2014-04-01

Last updated by the study team

2016-04-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects previously enrolled in Glaukos Study GC-003 who are able and willing to participate in this extended follow-up study

You may not qualify if…

• Subjects previously enrolled in Glaukos Study GC-003 who are not able or willing to participate in this extended follow-up study
• Patients not previously enrolled in Glaukos Study GC-003

Where it is running

• Study site — Beverly Hills, California, United States
• Study site — Petaluma, California, United States
• Study site — Sacramento, California, United States
• Study site — San Clemente, California, United States
• Study site — Santa Maria, California, United States
• Study site — Parker, Colorado, United States
• Study site — Boynton Beach, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Morrow, Georgia, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Overland Park, Kansas, United States
• Study site — Louisville, Kentucky, United States
• Study site — Baton Rouge, Louisiana, United States
• Study site — Saint Joseph, Michigan, United States
• Study site — Bloomington, Minnesota, United States
• Study site — Edina, Minnesota, United States
• Study site — Independence, Missouri, United States
• Study site — Kansas City, Missouri, United States
• Study site — Las Vegas, Nevada, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Brookville, Pennsylvania, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.